Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
International Journal of Clinical Oncology
Published in: International Journal of Clinical Oncology 4/2008

01-08-2008 | Original Article

PTD classification: proposal for a new classification of gastric cancer location based on physiological lymphatic flow

Authors: Shinichi Kinami, Takashi Fujimura, Eisuke Ojima, Sachio Fushida, Toshihiko Ojima, Hiroshi Funaki, Hideto Fujita, Hiroyuki Takamura, Itasu Ninomiya, Genichi Nishimura, Masato Kayahara, Tetsuo Ohta, Zen Yoh

Published in: International Journal of Clinical Oncology | Issue 4/2008

Login to get access
Metadata
Title
PTD classification: proposal for a new classification of gastric cancer location based on physiological lymphatic flow
Authors
Shinichi Kinami
Takashi Fujimura
Eisuke Ojima
Sachio Fushida
Toshihiko Ojima
Hiroshi Funaki
Hideto Fujita
Hiroyuki Takamura
Itasu Ninomiya
Genichi Nishimura
Masato Kayahara
Tetsuo Ohta
Zen Yoh
Publication date
01-08-2008
Publisher
Springer Japan
Published in
International Journal of Clinical Oncology / Issue 4/2008
Print ISSN: 1341-9625
Electronic ISSN: 1437-7772
DOI
https://doi.org/10.1007/s10147-007-0755-x

Other articles of this Issue 4/2008

International Journal of Clinical Oncology 4/2008 Go to the issue

Original Article

Concurrent chemoradiation for locally advanced squamous cell carcinoma of the vagina: case series and literature review

Review Article

Molecular pathogenesis of bladder cancer

Original Article

The predictive value of PgR and HER-2 for response to primary systemic chemotherapy in inflammatory breast cancer

Case Report

Cardiac metastases

Original Article

Chemotherapy with pegylated liposomal doxorubicin and cisplatin in recurrent platinum-sensitive epithelial ovarian cancer

Introduction to Review Articles

Current topics and perspectives in bladder cancer research
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits